Adaptive Biotechnologies Corp. (ADPT)
28.35
+0.98
(+3.58%)
USD |
NASDAQ |
Oct 02, 16:00
28.34
-0.02
(-0.05%)
Pre-Market: 20:00
Adaptive Biotechnologies EPS Diluted (Quarterly) : -0.2489 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2489 |
| March 31, 2026 | -0.1288 |
| December 31, 2025 | -0.0887 |
| September 30, 2025 | 0.0585 |
| June 30, 2025 | -0.1684 |
| March 31, 2025 | -0.2001 |
| December 31, 2024 | -0.2282 |
| September 30, 2024 | -0.2174 |
| June 30, 2024 | -0.3136 |
| March 31, 2024 | -0.3259 |
| December 31, 2023 | -0.4792 |
| September 30, 2023 | -0.3476 |
| June 30, 2023 | -0.3311 |
| March 31, 2023 | -0.402 |
| December 31, 2022 | -0.2805 |
| September 30, 2022 | -0.3168 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.3656 |
| March 31, 2022 | -0.4428 |
| December 31, 2021 | -0.435 |
| September 30, 2021 | -0.3969 |
| June 30, 2021 | -0.3512 |
| March 31, 2021 | -0.2925 |
| December 31, 2020 | -0.3254 |
| September 30, 2020 | -0.2733 |
| June 30, 2020 | -0.2633 |
| March 31, 2020 | -0.2491 |
| December 31, 2019 | -0.1657 |
| September 30, 2019 | -0.1122 |
| June 30, 2019 | -0.1317 |
| March 31, 2019 | -0.1513 |
| June 30, 2018 | -0.1005 |
| March 31, 2018 | -0.1005 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Personalis, Inc. | -0.3005 |
| 10X Genomics, Inc. | -0.138 |
| Alamar Biosciences, Inc. (California) | -0.1902 |
| Champions Oncology, Inc. | -0.0306 |
| Medpace Holdings, Inc. | 4.250 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.94M |
| Revenue (Quarterly) | 71.55M |
| Total Expenses (Quarterly) | 111.34M |
| Enterprise Value | 4.583B |
| Gross Profit Margin (Quarterly) | 70.15% |
| Profit Margin (Quarterly) | -55.82% |
| Earnings Yield | -1.44% |
| Normalized Earnings Yield | -1.055 |